Literature DB >> 30718261

Low stress resilience in late adolescence and risk of smoking, high alcohol consumption and drug use later in life.

Beatrice Kennedy1,2, Ruoqing Chen3,4, Fang Fang4, Unnur Valdimarsdottir4,5,6, Scott Montgomery3,7,8, Henrik Larsson3,4, Katja Fall3,4.   

Abstract

BACKGROUND: While compromised stress resilience constitutes a recognised risk factor for somatic and psychiatric disease development in general, the knowledge about how individual variation in vulnerability to stress may specifically influence the long-term risks of disadvantageous health behaviours is limited.
METHODS: In this Swedish cohort study, we aimed to investigate the association between stress resilience in late adolescence and adult use of addictive substances. We included 9381 men with information on psychological stress resilience measured during military conscription examinations, who later responded to an extensive health survey (mean age 34.0±7.2 years) including detailed information on substance use. We modelled continuous outcomes using linear regression, binary outcomes with logistic regression and other categorical outcomes with multinomial logistic regression.
RESULTS: We found that low stress resilience in adolescence conferred increased risks of all studied measures of addictive behaviour. After adjusting for childhood socioeconomic information, low stress resilience was associated with adult current regular smoking (relative risk ratio: 5.85, 95% CI 4.32 to 7.93), higher nicotine dependence scores (beta: 0.76, 95% CI 0.29 to 1.23), hazardous use of alcohol (>14 alcoholic drink-equivalents per week, OR: 1.72, 95% CI 1.37 to 2.16), DSM-IV criteria for alcohol dependence (OR: 1.74, 95% CI 1.35 to 2.25), and drug use (OR: 1.77, 95% CI 1.51 to 2.08). The results remained largely unchanged after further adjustments for adult educational attainment and occupation as well as for additional conscription covariates.
CONCLUSION: Low stress resilience in late adolescence appears to be associated with an increased risk of disadvantageous and addictive health behaviours in adulthood. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  alcohol; epidemiology; health behaviour; psychological stress; smoking

Year:  2019        PMID: 30718261     DOI: 10.1136/jech-2018-211815

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  6 in total

1.  Roles of alcohol use disorder and resilience in risk of suicide attempt in men: A Swedish population-based cohort.

Authors:  Séverine Lannoy; Henrik Ohlsson; Jan Sundquist; Kristina Sundquist; Alexis C Edwards
Journal:  Suicide Life Threat Behav       Date:  2022-01-03

Review 2.  America's opioid crisis: the need for an integrated public health approach.

Authors:  Carlos Blanco; Tisha R A Wiley; Jacqueline J Lloyd; Marsha F Lopez; Nora D Volkow
Journal:  Transl Psychiatry       Date:  2020-05-28       Impact factor: 6.222

3.  Family Function Impacts Relapse Tendency in Substance Use Disorder: Mediated Through Self-Esteem and Resilience.

Authors:  Yuwei Xia; Yu Gong; Hanbin Wang; Shen Li; Fuqiang Mao
Journal:  Front Psychiatry       Date:  2022-02-14       Impact factor: 4.157

Review 4.  Areas of Convergence and Divergence in Adolescent Social Isolation and Binge Drinking: A Review.

Authors:  Jyoti Lodha; Emily Brocato; Jennifer T Wolstenholme
Journal:  Front Behav Neurosci       Date:  2022-03-30       Impact factor: 3.617

5.  Barriers and facilitators of noncommunicable disease (NCD) prevention in Kerala: A qualitative study.

Authors:  Nisha K Jose; M V Sruthi; Jerry Rachel; Kerline Jerome; Clint Vaz; C R Saju
Journal:  J Family Med Prim Care       Date:  2022-06-30

Review 6.  Resilience to the effects of social stress on vulnerability to developing drug addiction.

Authors:  Claudia Calpe-López; Maria A Martínez-Caballero; Maria P García-Pardo; Maria A Aguilar
Journal:  World J Psychiatry       Date:  2022-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.